Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29327055

Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2018 Mar 1
First author
Gianni L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2018 Mar 1;4(3):293-295. doi: 10.1001/jamaoncol.2017.4651.
    note
    Source null
    related pmid
    29327056
    relationship
    Comment in

Authors and identifiers

  1. name
    Gianni L
    type
    Author
  2. name
    Mansutti M
    type
    Author
  3. name
    Anton A
    type
    Author
  4. name
    Calvo L
    type
    Author
  5. name
    Bisagni G
    type
    Author
  6. name
    Bermejo B
    type
    Author
  7. name
    Semiglazov V
    type
    Author
  8. name
    Thill M
    type
    Author
  9. name
    Chacon JI
    type
    Author
  10. name
    Chan A
    type
    Author
  11. name
    Morales S
    type
    Author
  12. name
    Alvarez I
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gianni L
    type
    Author
  2. name
    Mansutti M
    type
    Author
  3. name
    Anton A
    type
    Author
  4. name
    Calvo L
    type
    Author
  5. name
    Bisagni G
    type
    Author
  6. name
    Bermejo B
    type
    Author
  7. name
    Semiglazov V
    type
    Author
  8. name
    Thill M
    type
    Author
  9. name
    Chacon JI
    type
    Author
  10. name
    Chan A
    type
    Author
  11. name
    Morales S
    type
    Author
  12. name
    Alvarez I
    type
    Author
bibliography ids
  1. nci-bib-6f9e2e7976a3cd470f3cdadd
book metadata
content sha256
25a429a386ee4b5213a9d45bff00d4b76440da78275742ffc5c08823cb329fd7
document type
citation
dois
  1. 10.1001/jamaoncol.2017.4612
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:29327055
immutable id
pubmed:29327055@25a429a386ee4b5213a9d45bff00d4b76440da78275742ffc5c08823cb329fd7
journal
abbreviation
JAMA Oncol
issn electronic
2374-2445
issn print
2374-2437
issue
3
name
JAMA oncology
nlm unique id
101652861
pages
302-308
volume
4
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2018 Mar 1;4(3):293-295. doi: 10.1001/jamaoncol.2017.4651.
    note
    Source null
    related pmid
    29327056
    relationship
    Comment in
outcomes validated
false
pmid
29327055
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
dcf92942951a16405343cba86246c4c6659853b6a5fdedef98c8e0f50ca77044
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Mar 1
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29327055/
title
Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial.

Preserved source evidence · Not medical advice